Virometix Broadens Senior Leadership Team with Three Key Appointments
Virometix Broadens Senior Leadership Team with Three Key Appointments Virometix Broadens Senior Leadership Team with Three Key Appointments Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, today announced the expansion of its leadership team with the appointment of a Chief Scientific Officer and two additional Board members. Virometix filled a vacancy in its management team with the appointment of Dr. Lilli Stergiou to the position of Chief Scient...
Source: globalbankingandfinance.com